Octrooien

Intellectual Property Audit Plus Scheme 2018/19 (pdf)

May 11, 2018 | Tags: Octrooien , Merken

Unitary Patent and Unified Patent Court take a step forward (pdf)

Apr 30, 2018 | Tags: Octrooien

New patent fee regime at the UKIPO (pdf)

Mar 28, 2018 | Tags: Octrooien

Added subject matter woe at the EPO – how it’s best avoided (pdf)

Jan 10, 2018 | Tags: Octrooien

EPO Enlarged Board Decision G1/16 (pdf)

Dec 20, 2017 | Tags: Octrooien

The UK Supreme Court re-vitalises patent infringement by equivalents (pdf)

Jul 13, 2017 | Tags: Octrooien , Biosciences

IP Rights and Innovation in the Nuclear Industry (pdf)

Jul 5, 2017 | Tags: Octrooien

Streamlining of EPO Procedure (pdf)

Jun 16, 2017 | Tags: Octrooien

The EPO Grant Phase - Briefing Note (pdf)

May 9, 2017 | Tags: Octrooien

EU IP and Brexit (pdf)

Mar 31, 2017 | Tags: Octrooien , Merken , Modellen

The EPO raises the bar on plausibility when assessing inventive step: T488/16 - Dasatinib (pdf)

Feb 3, 2017 | Tags: Octrooien

Unitary Patent System – UPDATE (pdf)

Jan 18, 2017 | Tags: Octrooien

Dasatinib - post-filing data in Europe (pdf)

Dec 20, 2016 | Tags: Octrooien

Has the EPO's Enlarged Board detoxified "Poisonous Divisionals"? (pdf)

Dec 20, 2016 | Tags: Octrooien

UK IP Office Opinions - A Low Key Route to Challenging Validity (pdf)

Dec 20, 2016 | Tags: Octrooien

EPO Enlarged Board Referral on Disclaimers and Added Matter G1/16 (pdf)

Dec 20, 2016 | Tags: Octrooien